(ACKB) Ackermans & Van Haaren - Ratings and Ratios
Dredging, Palm Oil, Real Estate, Banking, Wind Farm
Description: ACKB Ackermans & Van Haaren
Ackermans & Van Haaren NV is a diversified holding company with operations in multiple sectors, including marine engineering and contracting, private banking, real estate and senior care, energy and resources, and growth capital. The companys diverse portfolio allows it to capitalize on various market opportunities and maintain a stable financial position.
The companys Marine Engineering & Contracting segment is a significant player in the industry, with activities ranging from dredging and civil works to offshore renewable energy and oil and gas. The Private Banking segment provides specialized financial services to private clients and entrepreneurs. The Real Estate & Senior Care segment develops mixed real estate projects, including residential, retail, and office properties. The Energy & Resources segment has operations in palm oil production, banana cultivation, and cement manufacturing.
From a financial perspective, Ackermans & Van Haaren NV has a market capitalization of approximately 7 billion EUR, with a price-to-earnings ratio of 15.22 and a forward P/E of 15.02. The companys return on equity (RoE) is 17.21%, indicating a relatively strong profitability. To further evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, EBITDA margin, and debt-to-equity ratio can be analyzed. For instance, a high EBITDA margin would indicate the companys ability to generate earnings from its operations, while a low debt-to-equity ratio would suggest a healthy capital structure.
Additional KPIs that can be used to assess Ackermans & Van Haaren NVs performance include its dividend yield, which can indicate the companys ability to distribute profits to shareholders, and its asset turnover ratio, which can measure the companys efficiency in utilizing its assets to generate revenue. By analyzing these KPIs, investors can gain a more comprehensive understanding of the companys financial health and growth prospects.
ACKB Stock Overview
| Market Cap in USD | 8,538m |
| Sub-Industry | Multi-Sector Holdings |
| IPO / Inception |
ACKB Stock Ratings
| Growth Rating | 81.2% |
| Fundamental | 69.7% |
| Dividend Rating | 62.3% |
| Return 12m vs S&P 500 | 11.6% |
| Analyst Rating | - |
ACKB Dividends
| Dividend Yield 12m | 1.84% |
| Yield on Cost 5y | 3.57% |
| Annual Growth 5y | 7.94% |
| Payout Consistency | 99.4% |
| Payout Ratio | 47.9% |
ACKB Growth Ratios
| Growth Correlation 3m | 17.9% |
| Growth Correlation 12m | 85.6% |
| Growth Correlation 5y | 85% |
| CAGR 5y | 15.49% |
| CAGR/Max DD 5y | 0.57 |
| Sharpe Ratio 12m | 1.16 |
| Alpha | 15.01 |
| Beta | 0.356 |
| Volatility | 17.26% |
| Current Volume | 40.3k |
| Average Volume 20d | 21.3k |
| Stop Loss | 214.9 (-3%) |
| Signal | -3.16 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (859.1m TTM) > 0 and > 6% of Revenue (6% = 675.9m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 5.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -22.87% (prev -72.76%; Δ 49.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 2.05b > Net Income 859.1m (YES >=105%, WARN >=100%) |
| Net Debt (6.66b) to EBITDA (2.02b) ratio: 3.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.7m) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 18.26% (prev 8.46%; Δ 9.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 57.31% (prev 23.14%; Δ 34.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.32 (EBITDA TTM 2.02b / Interest Expense TTM 358.6m) >= 6 (WARN >= 3) |
Altman Z'' 0.37
| (A) -0.13 = (Total Current Assets 7.97b - Total Current Liabilities 10.54b) / Total Assets 20.29b |
| (B) 0.24 = Retained Earnings (Balance) 4.96b / Total Assets 20.29b |
| (C) 0.06 = EBIT TTM 1.19b / Avg Total Assets 19.66b |
| (D) 0.00 = Book Value of Equity 2.29m / Total Liabilities 13.48b |
| Total Rating: 0.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.68
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 9.90% = 4.95 |
| 3. FCF Margin 11.57% = 2.89 |
| 4. Debt/Equity 1.85 = 0.99 |
| 5. Debt/Ebitda 4.85 = -2.50 |
| 6. ROIC - WACC 2.99% = 3.74 |
| 7. RoE 17.21% = 1.43 |
| 8. Rev. Trend 89.83% = 4.49 |
| 9. Rev. CAGR 19.40% = 2.43 |
| 10. EPS Trend 10.43% = 0.26 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of ACKB shares?
Over the past week, the price has changed by -3.23%, over one month by +2.69%, over three months by -1.25% and over the past year by +30.57%.
Is Ackermans & Van Haaren a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACKB is around 244.74 EUR . This means that ACKB is currently undervalued and has a potential upside of +10.44% (Margin of Safety).
Is ACKB a buy, sell or hold?
What are the forecasts/targets for the ACKB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 234.7 | 5.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 261.1 | 17.8% |
ACKB Fundamental Data Overview
Market Cap EUR = 7.33b (7.33b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 3.94b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 15.8974
P/E Forward = 15.674
P/S = 1.2129
P/B = 1.3813
Beta = 0.749
Revenue TTM = 11.26b EUR
EBIT TTM = 1.19b EUR
EBITDA TTM = 2.02b EUR
Long Term Debt = 2.39b EUR (from longTermDebt, last quarter)
Short Term Debt = 7.39b EUR (from shortTermDebt, last quarter)
Debt = 9.78b EUR (Calculated: Short Term 7.39b + Long Term 2.39b)
Net Debt = 6.66b EUR (from netDebt column, last quarter)
Enterprise Value = 13.17b EUR (7.33b + Debt 9.78b - CCE 3.94b)
Interest Coverage Ratio = 3.32 (Ebit TTM 1.19b / Interest Expense TTM 358.6m)
FCF Yield = 9.90% (FCF TTM 1.30b / Enterprise Value 13.17b)
FCF Margin = 11.57% (FCF TTM 1.30b / Revenue TTM 11.26b)
Net Margin = 7.63% (Net Income TTM 859.1m / Revenue TTM 11.26b)
Gross Margin = 18.26% ((Revenue TTM 11.26b - Cost of Revenue TTM 9.21b) / Revenue TTM)
Tobins Q-Ratio = 5739 (set to none) (Enterprise Value 13.17b / Book Value Of Equity 2.29m)
Interest Expense / Debt = 1.08% (Interest Expense 106.0m / Debt 9.78b)
Taxrate = 18.95% (from yearly Income Tax Expense: 141.0m / 744.2m)
NOPAT = 965.0m (EBIT 1.19b * (1 - 18.95%))
Current Ratio = 0.76 (Total Current Assets 7.97b / Total Current Liabilities 10.54b)
Debt / Equity = 1.85 (Debt 9.78b / last Quarter total Stockholder Equity 5.28b)
Debt / EBITDA = 4.85 (Net Debt 6.66b / EBITDA 2.02b)
Debt / FCF = 7.51 (Debt 9.78b / FCF TTM 1.30b)
Total Stockholder Equity = 4.99b (last 4 quarters mean)
RoA = 4.23% (Net Income 859.1m, Total Assets 20.29b )
RoE = 17.21% (Net Income TTM 859.1m / Total Stockholder Equity 4.99b)
RoCE = 16.12% (Ebit 1.19b / (Equity 4.99b + L.T.Debt 2.39b))
RoIC = 6.63% (NOPAT 965.0m / Invested Capital 14.55b)
WACC = 3.64% (E(7.33b)/V(17.11b) * Re(7.33%)) + (D(9.78b)/V(17.11b) * Rd(1.08%) * (1-Tc(0.19)))
Shares Correlation 5-Years: -90.0 | Cagr: -0.36%
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 75.77% ; FCFE base≈858.3m ; Y1≈733.8m ; Y5≈568.9m
Fair Price DCF = 318.3 (DCF Value 10.40b / Shares Outstanding 32.7m; 5y FCF grow -17.64% → 3.0% )
Revenue Correlation: 89.83 | Revenue CAGR: 19.40%
Rev Growth-of-Growth: 24.21
EPS Correlation: 10.43 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 103.7